POLBF:Poolbeg Pharma plc - Stock Price Quote and Dividend Data
POLBF STOCK PRICE LATEST CLOSE
$0.12
EXCHANGE
OTCBB
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Poolbeg Pharma plc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Poolbeg Pharma plc Stock Price Information
52-Week Low/High Stock Price$0.11 - $0.23
Percent Held by Institutions0.00%
Revenue$0
Net Income$-3,931,000
Cash Flow$-4,381,000
EPS0.00%
Market Cap$0
PE Ratio to Industry54%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.82%
Total Return Last 12 Months2.61%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateNov. 07, 2024
Poolbeg Pharma plc Annual Stock Dividends
No Data available for Payment History.
Poolbeg Pharma plc Dividend Payment History
| No dividends retrieved for POLBF |
Poolbeg Pharma plc Other Dividend Details
Poolbeg Pharma is a clinical stage infectious diseases pharmaceutical company. Co. is engaged in the research and development of vaccines and treatments for infectious diseases. Co.'s areas of the business are engaged in the development of pharmaceutical product. Co. has several infectious disease products and platforms, including: POLB 001, a treatment for severe influenza; POLB 002, an inlicensed intranasally administered, RNAbased immunotherapy for respiratory virus infections; and an option to license and evaluate an intramuscular vaccine to prevent Melioidosis (POLB 003), a disease predominately found in tropical and subtropical regions, and additional bacterial vaccine candidates.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Nov. 08, 2024POLBF STOCK PRICE DECREASE: Poolbeg Pharma plc on 11-08-2024 decreased stock price > 10% from $0.15 to $0.12
Aug. 02, 2024POLBF STOCK PRICE DECREASE: Poolbeg Pharma plc on 08-02-2024 decreased stock price > 10% from $0.17 to $0.15
Jun. 27, 2024POLBF STOCK PRICE DECREASE: Poolbeg Pharma plc on 06-27-2024 decreased stock price > 10% from $0.20 to $0.17
May. 08, 2024POLBF STOCK PRICE INCREASE: Poolbeg Pharma plc on 05-08-2024 increased stock price > 10% from $0.15 to $0.23
May. 08, 2024POLBF STOCK PRICE 52 WEEK HIGH: Poolbeg Pharma plc on 05-08-2024 hit a 52 week high of $0.23
May. 02, 2024POLBF STOCK PRICE 52 WEEK HIGH: Poolbeg Pharma plc on 05-02-2024 hit a 52 week high of $0.15
Apr. 27, 2024POLBF STOCK PRICE INCREASE: Poolbeg Pharma plc on 04-27-2024 increased stock price > 10% from $0.11 to $0.14
Apr. 27, 2024POLBF STOCK PRICE 52 WEEK HIGH: Poolbeg Pharma plc on 04-27-2024 hit a 52 week high of $0.14
Feb. 08, 2023POLBF STOCK PRICE INCREASE: Poolbeg Pharma plc on 02-08-2023 increased stock price > 10% from $0.10 to $0.12
Feb. 01, 2023POLBF STOCK PRICE INCREASE: Poolbeg Pharma plc on 02-01-2023 increased stock price > 10% from $0.07 to $0.10
Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00
Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66
Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08
Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06
Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94
Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20
Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12
Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83
Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13
